COVID-19 Data: mAb

CE / CME

The Monoclonal Antibodies Strike Back: New Data on Their Use in COVID-19

ABIM MOC : maximum of 0.75 Medical Knowledge MOC point(s)

Pharmacists: 0.75 contact hour (0.075 CEUs)

Physicians: Maximum of 0.75 AMA PRA Category 1 Credit

Nurses: 0.75 Nursing contact hour

Released: September 09, 2021

Expiration: September 08, 2022

Arthur Kim
Arthur Kim, MD
Sharon R. Lewin
Sharon R. Lewin, AO, FRACP, PhD, FAHMS

Activity

Progress
1
Course Completed

In this podcast episode, Sharon R. Lewin, AO, FRACP, PhD, FAHMS, and Arthur Kim, MD, discuss data on the potential use of monoclonal antibodies (mAb) for the prevention and treatment of COVID-19, including:

  • Rationale for use of mAb
  • Potential for resistance to mAb
  • Single vs combination therapy with mAb
  • Challenges in implementation of mAb as treatment or prevention
  • Bamlanivimab
  • Sotrovimab
  • Casirivimab plus imdevimab